ODDB.org: Open Drug Database

Axotide Nebules 0,5 mg/2 mL, gebrauchsfertige Suspension zur Inhalation - 10 Einzeldosen

Swissmedic Key	54592019	Registration Holder	GlaxoSmithKline AG
Name	Axotide Nebules 0,5 mg/2 mL, gebrauchsfertige Suspension zur Inhalation	Date of registration	25.06.1999
		Introduction of Sequence	25.06.1999
ATC-Classification	Fluticasone (R03BA05)	Revision date	25.10.2007
WHO	WHO-DDD	Valid until	24.10.2017
Index Therapeuticus (BSV)	03.04.40.	Show package size	10 Einzeldosen
Index Therapeuticus (Swissmedic)	03.04.40.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	9.06
Deductible	k.A.	Consumer price	18.60
Feedback	FB
GTIN	7680545920198	Medication Code	Synthetika human
Pharmacode		Disponibility

Composition

fluticasoni-17 propionas 0.5 mg, excipiens ad suspensionem pro 2 ml.

Packungsbestandteile

Galenic Form

gebrauchsfertige Suspension zur Inhalation

Excipiens

Active Agent	Dose
Fluticasoni-17 Propionas	0.5 mg

Source

Data was imported : 04.12.2014 Swissmedic Registration : 54592 Sequence : 01 Product name : Axotide Nebules 0,5 mg/2 mL, gebrauchsfertige Suspension zur Inhalation Registration owner: : GlaxoSmithKline AG Product group : Index Therapeuticus (BSV) : 03.04.4. Medication Code : Synthetika human Date of registration : 25.06.1999 Valid until : 24.10.2017 Package number : 019 Show package size : 10 Commercial Form/Unit : Einzeldose(n) Swissmedic categorie. : B Active Agents : fluticasoni-17 propionas Composition : fluticasoni-17 propionas 0.5 mg, excipiens ad suspensionem pro 2 ml.

2025	©ywesee GmbH